drugset / Trial / NCT01969032
Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to increase survival of patients with locally advanced triple-negative breast cancer using two consequent induction preoperative chemotherapy regimens.
Timeline
- Start
- 2011-08
- Primary completion
- 2014-05
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Capecitabine | Small molecule | 500 mg | — |
| Background | Carboplatin | Small molecule | 2 unknown | Intravenous |
| Background | Cyclophosphamide | Other / unclassified | 50 mg | Oral |
| Background | Doxorubicin | Other / unclassified | 25 mg/m2 | Intravenous |
| Background | Paclitaxel | Small molecule | 60 mg/m2 | Intravenous |